City
Bay Area
45 published announcements name Bay Area. The city or office the release names.
Most recent
SEARCH ALL 45 Latham & Watkins Advises American Real Estate Partners in Acquisition of a Minority Interest by Brookfield 17 Sept 2026
Latham & Watkins Advises Wonder on Its Strategic Partnership With DoorDash 17 Sept 2026
Latham & Watkins Advises Sequence AI Holdings in US$7.7 Billion Take-Private Acquisition of The Baldwin Group 17 Sept 2026
Latham Advises General Catalyst and a16z on Mistral AI’s €3 Billion Series D Funding Round 17 Sept 2026
Latham & Watkins Advises Carrick Capital Partners on Oversubscribed Continuation Vehicle and Commitment of US$255 Million New Capital to Saviynt 3 Sept 2026
Latham & Watkins Advises AMD in River AI’s US$1.1 Billion Funding 28 Aug 2026
Latham & Watkins Advises CaTECH in Acquisition of Envision Technology Group 28 Aug 2026
Latham & Watkins Advises Veritas Capital on US$1.1 Billion Sale of Epiq Solutions to TTM Technologies 19 Aug 2026
Latham & Watkins Advises AMD in US$4.75 Billion Senior Notes Offering 15 Aug 2026
Latham & Watkins Advises Dorsch Global on the Sale of Vela Tech 15 Aug 2026
Latham Advises Medical Faculty Associates in Transaction With the George Washington University and Universal Health Services 11 Aug 2026
Latham & Watkins Advises Bowman Consulting Group in US$1 Billion Acquisition by Bernhard Capital Partners 11 Aug 2026
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Latham & Watkins Advises Sequoia Capital on Valar Atomics’ US$1 Billion Series B Financing 6 Aug 2026
Latham & Watkins Advises WestView Capital Partners in Sale of Unified Patents to Anaqua 6 Aug 2026
Latham & Watkins Advises Silver Lake in Completed US$55 Billion Acquisition of Electronic Arts 5 Aug 2026
Latham & Watkins Advises Permira on US$2.4 Billion Sale of BioCatch to Visa 4 Aug 2026
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
Latham & Watkins Advises on Reformation’s US$210.9 Million IPO 31 Jul 2026
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Latham Advises Crusoe on Partnership With ON.energy to Power AI infrastructure 24 Jul 2026
Latham Advises on Completed US$40 Billion Sale of Aligned Data Centers by Macquarie Asset Management 22 Jul 2026
Latham & Watkins Advises TYLsemi on US$43 Million Financing 15 Jul 2026
Latham Advises on Alto Neuroscience’s US$100 Million Underwritten Registered Direct Offering of Common Stock 14 Jul 2026
Latham & Watkins Advises Together AI in US$800 Million Series C 8 Jul 2026
Latham & Watkins Advises Reap Technologies in Completed Acquisition by Payward 2 Jul 2026
Latham & Watkins Advises Meta on Investment in CRED 1 Jul 2026
Latham & Watkins Advises Revmatics on Acquisition of DataFeedWatch 30 Jun 2026
Latham & Watkins Advises Sony Pictures Entertainment in US$100 Million Strategic Investment in Cosm 30 Jun 2026
Latham & Watkins Advises Vibe.co in Acquisition by Walmart 25 Jun 2026
Latham & Watkins Advises AMD on Acquisition of MEXT 17 Jun 2026
Latham & Watkins Advises Hybar in US$400 Million Senior Secured Green Notes Offering 17 Jun 2026
Latham & Watkins Advises Comoto on Investment by Gemspring Capital 16 Jun 2026
Latham & Watkins Advises on Digital Asset’s US$355 Million Funding Round to Accelerate Canton’s Role as Onchain Infrastructure for Capital Markets 16 Jun 2026
Latham Advises Warburg Pincus on Tender Offer for J.S.B. 16 Jun 2026
Latham & Watkins Advises on US$7 Billion Equity and Equity‑Linked Financing Transactions for Supermicro 12 Jun 2026
Lights Entertainment in Sale of US Showcase Cinemas Portfolio to Kinepolis 12 Jun 2026
Latham & Watkins Advises on Shattuck Labs’ US$75 Million Public Offering 11 Jun 2026
Latham & Watkins Advises on Hark’s US$700 Million Series A at US$6 Billion Valuation 11 Jun 2026
Latham & Watkins Advises IDEAYA Biosciences on US$300 Million Offering of Common Stock and Pre‑Funded Warrants 11 Jun 2026
Latham & Watkins Advises Health Catalyst on Divestiture of Vitalware 8 Jun 2026
Latham & Watkins Advises Blackstone on Investment in Anthropic’s US$65 Billion Series H at a US$965 Billion Valuation 31 May 2026
Latham & Watkins Advises Exa in US$250 Million Series C at US$2.2 Billion Valuation 25 May 2026
Latham & Watkins Advises SPR Therapeutics in US$650 Acquisition by Medtronic 25 May 2026
Latham & Watkins Advises PSP Investments on Sale of FirstLight’s US Portfolio to Hull Street Energy 20 May 2026